Fibroblast extracellular matrix synthesis stimulation

Fibroblast extracellular matrix synthesis stimulation refers to the process by which fibroblasts—principal cells of connective tissue—are activated to produce and secrete extracellular matrix proteins including collagen, fibronectin, and glycosaminoglycans. This process is critical in normal tissue repair, maintenance, and wound healing but becomes maladaptive in pathological states such as fibrosis and cancer, where persistent fibroblast activation leads to excessive ECM accumulation and altered tissue architecture. Major molecular regulators include the transforming growth factor-beta (TGF-β) pathway, integrins (ECM receptors), and metabolic changes such as increased glycolysis and amino acid synthesis.

Other names

ECM synthesis in fibroblastsfibroblast-driven matrix productionstimulation of ECM synthesis in fibroblasts

Mechanisms for drugs impacting this process include: Inhibition of TGF-β mediated fibroblast activation; Blocking integrin-mediated signal transduction; Inhibiting enzymatic collagen cross-linking (lysyl oxidase inhibitors); Modulating matrix metalloproteinase activity to balance ECM synthesis and degradation.